Search research articles
Contact Us
Filters
Showing results (211-220 of 236) with videos related to
Page
of 24
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 26, 2022
Autosomal Dominant Hypocalcemia Type 1: A Systematic Review
Kelly L Roszko, Lyndsay M Stapleton Smith, Ananth V Sridhar, et al.
BMJ Open
|
March 24, 2021
Gender parity in scientific authorship in a National Institute for Health Research Biomedical Research Centre: a bibliometric analysis
Syed Ghulam Sarwar Shah, Rinita Dam, Maria Julia Milano, et al.
Biology Letters
|
July 5, 2007
Heterotrophic microbial communities use ancient carbon following glacial retreat
Richard D Bardgett, Andreas Richter, Roland Bol, et al.
The New England Journal of Medicine
|
September 27, 2023
Efficacy and Safety of Encaleret in Autosomal Dominant Hypocalcemia Type 1
Rachel I Gafni, Iris R Hartley, Kelly L Roszko, et al.
Journal of Exposure Science & Environmental Epidemiology
|
April 30, 2026
Use of a capillary blood collection device to monitor exposure to per- and polyfluoroalkyl substances (PFAS) in Veterans living in proximity to potential sources of environmental contamination
Lauren A Havens, Elizabeth R Heitz, Kelsie R Hartley, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 25, 2024
Spatial Atlas for Mapping Vascular Microcalcification Using 18F-NaF PET/CT: Application in Hyperphosphatemic Familial Tumoral Calcinosis
Aaron J Sheppard, Elizabeth H Theng, Sriram S Paravastu, et al.
Ophthalmology
|
June 25, 2021
Reply
M Teresa Magone, Iris R Hartley, Edmond FitzGibbon, et al.
Ophthalmology
|
September 5, 2020
Ocular Adverse Effects of Infigratinib, a New Fibroblast Growth Factor Receptor Tyrosine Kinase Inhibitor
M Teresa Magone, Iris R Hartley, Edmond Fitzgibbon, et al.
JBMR Plus
|
August 22, 2022
Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor-Induced Osteomalacia
Iris R Hartley, Kelly L Roszko, Xiaobai Li, et al.
JBMR Plus
|
May 12, 2021
A Cross-Sectional Cohort Study of the Effects of FGF23 Deficiency and Hyperphosphatemia on Dental Structures in Hyperphosphatemic Familial Tumoral Calcinosis
Alisa E Lee, Emily Y Chu, Pamela J Gardner, et al.
Page
of 24
Search research articles
Search
Showing results (211-220 of 236) with videos related to
Sort By:
Page
of 24
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
July 26, 2022
Autosomal Dominant Hypocalcemia Type 1: A Systematic Review
Kelly L Roszko, Lyndsay M Stapleton Smith, Ananth V Sridhar, et al.
BMJ Open
|
March 24, 2021
Gender parity in scientific authorship in a National Institute for Health Research Biomedical Research Centre: a bibliometric analysis
Syed Ghulam Sarwar Shah, Rinita Dam, Maria Julia Milano, et al.
Biology Letters
|
July 5, 2007
Heterotrophic microbial communities use ancient carbon following glacial retreat
Richard D Bardgett, Andreas Richter, Roland Bol, et al.
The New England Journal of Medicine
|
September 27, 2023
Efficacy and Safety of Encaleret in Autosomal Dominant Hypocalcemia Type 1
Rachel I Gafni, Iris R Hartley, Kelly L Roszko, et al.
Journal of Exposure Science & Environmental Epidemiology
|
April 30, 2026
Use of a capillary blood collection device to monitor exposure to per- and polyfluoroalkyl substances (PFAS) in Veterans living in proximity to potential sources of environmental contamination
Lauren A Havens, Elizabeth R Heitz, Kelsie R Hartley, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
April 25, 2024
Spatial Atlas for Mapping Vascular Microcalcification Using 18F-NaF PET/CT: Application in Hyperphosphatemic Familial Tumoral Calcinosis
Aaron J Sheppard, Elizabeth H Theng, Sriram S Paravastu, et al.
Ophthalmology
|
June 25, 2021
Reply
M Teresa Magone, Iris R Hartley, Edmond FitzGibbon, et al.
Ophthalmology
|
September 5, 2020
Ocular Adverse Effects of Infigratinib, a New Fibroblast Growth Factor Receptor Tyrosine Kinase Inhibitor
M Teresa Magone, Iris R Hartley, Edmond Fitzgibbon, et al.
JBMR Plus
|
August 22, 2022
Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor-Induced Osteomalacia
Iris R Hartley, Kelly L Roszko, Xiaobai Li, et al.
JBMR Plus
|
May 12, 2021
A Cross-Sectional Cohort Study of the Effects of FGF23 Deficiency and Hyperphosphatemia on Dental Structures in Hyperphosphatemic Familial Tumoral Calcinosis
Alisa E Lee, Emily Y Chu, Pamela J Gardner, et al.
Page
of 24